Literature DB >> 12664062

High-grade intra-epithelial neoplasia and prostate cancer in Dibombari, Cameroon.

F F Angwafo1, A Zaher, R Befidi-Mengue, A Wonkam, I Takougang, I Powell, G Murphy.   

Abstract

High-grade prostatic intra-epithelial neoplasia (HGPIN) occurs a decade earlier in men of African descent in the US and Brazil, compared to white men. Prostate cancer incidence and mortality is worse in the African-American than in US white men. Sub-Saharan Africa was thought to be a low incidence area. This disparity has been attributed to lifestyle factors such as diet. We report the results of prostatic biopsies, from an ongoing national prostate cancer survey. One hundred and eleven men aged 40 y and over were recruited for medical interview (AUA symptom score), prostate specific antigen (PSA) assay and digital rectal examination (DRE). Between six and 10 cores of random digitally guided needle biopsies were performed on 24 subjects that had either suspicious prostates on digital rectal examination +/ or PSA > or =4 ng/ml. All lesions of the prostate were described on routine histopathology. The Gleason score and proportion of tissue involved with cancer, was determined. Eight men had benign prostatic hyperplasia (BPH), six had cancer, another six had low grade intra-epithelial neoplasia, two had HGPIN, there was one case of BPH and chronic prostatitis and one case of chronic prostatitis only. The cancer patients were aged 58-75 y (mean 66.93 y). Gleason scores ranged from 5 to 9, there was one score of 3. Cancer made up 20-80% tissue samples. HGPIN was found in two cases (mean age 58 y). Significant prostate cancer and the pre-cancerous lesion HGPIN exist in Dibombari, Cameroon. The purported low incidence of prostate cancer may reflect cultural and economic barriers to health care.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12664062     DOI: 10.1038/sj.pcan.4500587

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  7 in total

1.  Fading Frontiers: Pragmatic Paradigm of Urologic Practice in a changing Africa.

Authors:  Ff Angwafo Iii
Journal:  J West Afr Coll Surg       Date:  2012-10

2.  8q24 risk alleles in West African and Caribbean men.

Authors:  Adam B Murphy; Flora Ukoli; Vincent Freeman; Frankly Bennett; William Aiken; Trevor Tulloch; Kathleen Coard; Fru Angwafo; Rick A Kittles
Journal:  Prostate       Date:  2012-01-10       Impact factor: 4.104

Review 3.  Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Authors:  Tiffany A Wallace; Damali N Martin; Stefan Ambs
Journal:  Carcinogenesis       Date:  2011-04-03       Impact factor: 4.944

Review 4.  Mapping Evidence on the Burden of Breast, Cervical, and Prostate Cancers in Sub-Saharan Africa: A Scoping Review.

Authors:  Alfred Musekiwa; Maureen Moyo; Mohanad Mohammed; Zvifadzo Matsena-Zingoni; Halima Sumayya Twabi; Jesca Mercy Batidzirai; Geoffrey Chiyuzga Singini; Kabelo Kgarosi; Nobuhle Mchunu; Portia Nevhungoni; Patricia Silinda; Theodora Ekwomadu; Innocent Maposa
Journal:  Front Public Health       Date:  2022-06-16

5.  Chronic non-communicable diseases in Cameroon - burden, determinants and current policies.

Authors:  Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  Global Health       Date:  2011-11-23       Impact factor: 4.185

Review 6.  Impact of natural resources and research on cancer treatment and prevention: A perspective from Cameroon.

Authors:  Barnabas Bessem Orang-Ojong; Jose Edward Munyangaju; Ma Shang Wei; Miao Lin; Fan Guan Wei; Charles Foukunang; Yan Zhu
Journal:  Mol Clin Oncol       Date:  2013-05-27

7.  Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT.

Authors:  Shahriar Koochekpour; Stacey S Willard; Mojgan Shourideh; Shafat Ali; Chunhong Liu; Gissou Azabdaftari; Mohammad Saleem; Kristopher Attwood
Journal:  Int J Biol Sci       Date:  2014-07-26       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.